You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 6, June 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Alterations in Brain High-Energy Phosphate and Membrane Phospholipid Metabolism in First-Episode, Drug-Naive Schizophrenics

A Pilot Study of the Dorsal Prefrontal Cortex by In Vivo Phosphorus 31 Nuclear Magnetic Resonance Spectroscopy

Jay W. Pettegrew, MD; Matcheri S. Keshavan, MD; Kanagasabai Panchalingam, PhD; Sandra Strychor, MPH; David B. Kaplan; Marjorie G. Tretta, RN; Maureen Allen, MPH

Arch Gen Psychiatry. 1991;48(6):563-568.


Abstract

• In this pilot study, membrane phospholipid and high-energy phosphate metabolism were studied in the dorsal prefrontal cortex of 11 drug-naive, first-episode schizophrenic patients and compared with those of 10 healthy control volunteers comparable in age, education, and parental education. The schizophrenic patients had significantly reduced levels of phosphomonoesters and inorganic orthophosphate and significantly increased levels of phosphodiesters and adenosine triphosphate compared with the controls. The levels of phosphocreatine and adenosine diphosphate did not differ in the two subject groups. The adenosine triphosphate and inorganic orthophosphate findings suggest functional hypoactivity of the dorsal prefrontal cortex. The phosphomonoester and phosphodiester findings are compatible with either premature aging or an exaggeration of normal programmed regressive events occurring in the neural systems sampled.



Author Affiliations

From the Center for Membrane Studies, Laboratory of Neurophysics, Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pa.


Footnotes

Accepted for publication December 19, 1990.

Reprint requests to Center for Membrane Studies, Laboratory of Neurophysics, Department of Psychiatry, Western Psychiatric Institute and Clinic, 3811 O'Hara St, Pittsburgh, PA 15213 (Dr Pettegrew).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro
HeiSer et al.
J Psychopharmacol 2007;21:851-856.
ABSTRACT  

Deconstructing Psychosis With Human Brain Imaging
Gur et al.
Schizophr Bull 2007;33:921-931.
ABSTRACT | FULL TEXT  

Chromatin Alterations Associated With Down-regulated Metabolic Gene Expression in the Prefrontal Cortex of Subjects With Schizophrenia
Akbarian et al.
Arch Gen Psychiatry 2005;62:829-840.
ABSTRACT | FULL TEXT  

Neurobiology of early psychosis
KESHAVAN et al.
Br. J. Psychiatry 2005;187:s8-s18.
ABSTRACT | FULL TEXT  

Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia
Middleton et al.
J. Neurosci. 2002;22:2718-2729.
ABSTRACT | FULL TEXT  

High Choline Concentrations in the Caudate Nucleus in Antipsychotic-Naive Patients With Schizophrenia
Bustillo et al.
Am. J. Psychiatry 2002;159:130-133.
ABSTRACT | FULL TEXT  

Book Review: Neural Network Models of Schizophrenia
Hoffman and Mcglashan
Neuroscientist 2001;7:441-454.
ABSTRACT  

Aberrant Tyrosine Transport Across the Cell Membrane in Patients With Schizophrenia
Flyckt et al.
Arch Gen Psychiatry 2001;58:953-958.
ABSTRACT | FULL TEXT  

Cerebral Phosphate Metabolism in First-Degree Relatives of Patients With Schizophrenia
Klemm et al.
Am. J. Psychiatry 2001;158:958-960.
ABSTRACT | FULL TEXT  

Informed Consent and Neuroanatomic Correlates of Intentionality and Voluntariness Among Psychiatric Patients
Grimes et al.
Psychiatr. Serv. 2000;51:1561-1567.
ABSTRACT | FULL TEXT  

Reduced Dorsal and Orbital Prefrontal Gray Matter Volumes in Schizophrenia
Gur et al.
Arch Gen Psychiatry 2000;57:761-768.
ABSTRACT | FULL TEXT  

Schizophrenia as a Disorder of Developmentally Reduced Synaptic Connectivity
McGlashan and Hoffman
Arch Gen Psychiatry 2000;57:637-648.
ABSTRACT | FULL TEXT  

Creatine and Creatinine Metabolism
Wyss and Kaddurah-Daouk
Physiol. Rev. 2000;80:1107-1213.
ABSTRACT | FULL TEXT  

Is There a Neuropathology of Schizophrenia? Recent Findings Converge on Altered Thalamic-Prefrontal Cortical Connectivity
Lewis
Neuroscientist 2000;6:208-218.
ABSTRACT  

Visual Perception and Working Memory in Schizotypal Personality Disorder
Farmer et al.
Am. J. Psychiatry 2000;157:781-788.
ABSTRACT | FULL TEXT  

Magnetic resonance spectroscopy: Bridging the neurochemistry and neuroanatomy of schizophrenia
BUCKLEY and FRIEDMAN
Br. J. Psychiatry 2000;176:203-205.
FULL TEXT  

Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz and Lewis
Arch Gen Psychiatry 2000;57:65-73.
ABSTRACT | FULL TEXT  

Searching for the Neuropathology of Schizophrenia: Neuroimaging Strategies and Findings
Am. J. Psychiatry 1999;156:1133-1136.
FULL TEXT  

Changes in Levels of Phosphorus Metabolites in Temporal Lobes of Drug-Naive Schizophrenic Patients
Fukuzako et al.
Am. J. Psychiatry 1999;156:1205-1208.
ABSTRACT | FULL TEXT  

Magnetic Resonance Spectroscopy in Affective Disorders
Kato et al.
J. Neuropsychiatry Clin. Neurosi. 1998;10:133-147.
ABSTRACT | FULL TEXT  

Sustained Remission of Positive and Negative Symptoms of Schizophrenia Following Treatment With Eicosapentaenoic Acid
Puri and Richardson
Arch Gen Psychiatry 1998;55:188-189.
FULL TEXT  

Synaptic Elimination, Neurodevelopment, and the Mechanism of Hallucinated "Voices" in Schizophrenia
Hoffman and McGlashan
Am. J. Psychiatry 1997;154:1683-1689.
ABSTRACT | FULL TEXT  

Reduction of Synaptophysin Immunoreactivity in the Prefrontal Cortex of Subjects With Schizophrenia: Regional and Diagnostic Specificity
Glantz and Lewis
Arch Gen Psychiatry 1997;54:943-952.
ABSTRACT  

Measurement of Glutamate and Glutamine in the Medial Prefrontal Cortex of Never-Treated Schizophrenic Patients and Healthy Controls by Proton Magnetic Resonance Spectroscopy
Bartha et al.
Arch Gen Psychiatry 1997;54:959-965.
ABSTRACT  

Reduction of Synaptophysin Immunoreactivity in the Prefrontal Cortex of Subjects With Schizophrenia: Regional and Diagnostic Specificity
Glantz and Lewis
Arch Gen Psychiatry 1997;54:660-669.
ABSTRACT  

Increased Phospholipid Breakdown in Schizophrenia: Evidence for the Involvement of a Calcium-Independent Phospholipase A2
Ross et al.
Arch Gen Psychiatry 1997;54:487-494.
ABSTRACT  

Phosphorus 31 Magnetic Resonance Spectroscopy in Patients With Huntington Disease-Reply
Pettegrew and Keshavan
Arch Gen Psychiatry 1997;54:187-188.
ABSTRACT  

Alterations of Membrane Phospholipid Metabolism in Patients With Schizophrenia Assessed by Phosphorus Magnetic Resonance Spectroscopy
George and Spence
Arch Gen Psychiatry 1996;53:1065-1066.
ABSTRACT  

Abnormally High Neuronal Density in the Schizophrenic Cortex: A Morphometric Analysis of Prefrontal Area 9 and Occipital Area 17
Selemon et al.
Arch Gen Psychiatry 1995;52:805-818.
ABSTRACT  

Neocortical Abnormalities in Schizophrenia
Watson and Meador-Woodruff
Arch Gen Psychiatry 1995;52:819-820.
ABSTRACT  

An In Vivo Study of the Prefrontal Cortex of Schizophrenic Patients at Different Stages of Illness via Phosphorus Magnetic Resonance Spectroscopy
Stanley et al.
Arch Gen Psychiatry 1995;52:399-406.
ABSTRACT  

Arachidonic Acid: A Common Link in the Biology of Schizophrenia?
Peet et al.
Arch Gen Psychiatry 1994;51:665-666.
ABSTRACT  

Schizophrenia as a Brain Disease
Williamson
Arch Neurol 1993;50:1096-1097.
ABSTRACT  

Effects of Metabolic Perturbation on Plasma Homovanillic Acid in Schizophrenia: Relationship to Prefrontal Cortex Volume
Breier et al.
Arch Gen Psychiatry 1993;50:541-550.
ABSTRACT  

Altered Distribution of Nicotinamide-Adenine Dinucleotide Phosphate--Diaphorase Cells in Frontal Lobe of Schizophrenics Implies Disturbances of Cortical Development
Akbarian et al.
Arch Gen Psychiatry 1993;50:169-177.
ABSTRACT  

Distorted Distribution of Nicotinamide-Adenine Dinucleotide Phosphate--Diaphorase Neurons in Temporal Lobe of Schizophrenics Implies Anomalous Cortical Development
Akbarian et al.
Arch Gen Psychiatry 1993;50:178-187.
ABSTRACT  

Phosphomonoesters and Phosphodiesters in the Brains of Schizophrenic Patients
Brown
Arch Gen Psychiatry 1992;49:416-416.
ABSTRACT  

Phosphomonoesters and Phosphodiesters in the Brains of Schizophrenic Patients-Reply
Pettegrew et al.
Arch Gen Psychiatry 1992;49:417-417.
ABSTRACT  

Phosphomonoesters and Phosphodiesters in the Brains of Schizophrenic Patients-Reply
Williamson et al.
Arch Gen Psychiatry 1992;49:416-417.
ABSTRACT  

Phosphorus 31 Magnetic Resonance Spectroscopy Detects Altered Brain Metabolism Before Onset of Schizophrenia
Keshavan et al.
Arch Gen Psychiatry 1991;48:1112-1113.
ABSTRACT  

Magnetic Resonance Spectroscopy: A Technique for Functional Brain Imaging
Guze
Arch Gen Psychiatry 1991;48:572-574.
ABSTRACT  

Localized Phosphorus 31 Magnetic Resonance Spectroscopy in Chronic Schizophrenic Patients and Normal Controls
Williamson et al.
Arch Gen Psychiatry 1991;48:578-578.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.